Zymeworks BC Target Price

Where could ZYME trade next? Consensus target price: $40.

Get informed when a big investor buys or sells

+ Follow

Share Price

$29.9

Average Target Price

$39.80

33.1% upside

10 analysts in the last 4 months

High: $55 | Low: $28

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-26	H.C. Wainwright	$55	83.9% upside
2026-08-26	Deutsche Bank	$32	7% upside
2026-08-07	Truist FinancialGregory Renza	$32	7% upside
2026-08-07	Stifel Nicolaus	$46	53.8% upside
2026-08-07	Wells Fargo	$40	33.8% upside
2026-08-05	H.C. Wainwright	$51	70.6% upside
2026-07-07	Truist Financial	$31	3.7% upside
2026-06-30	Wells Fargo	$37	23.7% upside
2026-06-09	Truist FinancialGregory Renza	$28	6.4% downside
2026-06-03	H.C. WainwrightAndrew Berens	$46	53.8% upside
2026-03-09	Evercore ISI	$48	60.5% upside
2025-12-17	Truist FinancialAsthika Goonewardene	$40	33.8% upside
2025-12-12	Wells Fargo	$33	10.4% upside
2025-12-03	JMP Securities	$32	7% upside
2025-11-19	Wells FargoEva Verdejo	$25	16.4% downside
2025-11-19	Stifel NicolausStephen Willey	$40	33.8% upside
2025-11-17	Leerink PartnersAndrew Berens	$37	23.7% upside
2025-10-14	H.C. WainwrightRobert Burns	$26	13% downside
2024-11-21	Leerink PartnersAndrew Berens	$26	13% downside
2024-11-01	Wells FargoDerek Archila	$12	59.9% downside
2024-10-28	Stifel NicolausStephen Willey	$28	6.4% downside
2024-09-25	H.C. WainwrightRobert Burns	$12	59.9% downside
2024-09-18	H.C. WainwrightAndrew Berens	$10	66.6% downside
2024-09-10	Stifel NicolausStephen Willey	$21	29.8% downside
2022-12-19	JefferiesAkash Tewari	$11	63.2% downside
2022-11-01	H.C. WainwrightRobert Burns	$8	73.2% downside
2021-09-20	H.C. WainwrightRobert Burns	$44	47.2% upside

Zymeworks BC (ZYME) FAQ

Zymeworks BC (ZYME) currently reports a target price of $40. Use the charts on this page to explore Zymeworks BC's target price history and peer comparisons.

Analysts' average 12-month price target for Zymeworks BC is $40, about 33.1% upside from the current share price of $29.9. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $40, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Zymeworks BC, and consider following ZYME for alerts when major investors trade the stock.

Zymeworks BC is classified in the Healthcare sector. On target price, it currently shows $40. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ZYME with unrelated industries.